About Mabgen
Mabgen is a Healthcare company based in Houston (United States) founded in 2004. Cytotoxicity screening devices for drug discovery are developed by Mabgen. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Assays and Cell Based Assays. Its competitors include Altis Biosystems and Aurita Bioscience Corporation; 2 of its 2 listed competitors have raised funding.
Company details
Mabgen was founded in 2004 in Houston, United States, and operates within the biotechnology sector focused on drug discovery tools. Cytotoxicity screening devices are developed to aid in identifying potential treatments. The Ab-Sniffer, a fiber optic fluorescence-based device, is provided for detecting functional drug candidates applicable to cancer and various other diseases. Operations emphasize precision in screening processes for pharmaceutical research.
- Headquarters Houston, United States
- SectorsHealthcare
- Phone•••• ••••
- Website mabgenllc.com
Competitors of Mabgen
Mabgen has 2 listed competitors in our database, 2 of them funded. They include Altis Biosystems and Aurita Bioscience Corporation.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| altisbiosystems.com | 2015 | Durham, United States | $7.53M | Provider of invitro platform for drug testing | ||
| auritabio.com | 2021 | Gainesville, United States | $180,491 | Developer of three-dimensional bioscience products and tools for research and clinical settings |
Detailed competitors of Mabgen
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Mabgen (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Mabgen
Mabgen was founded in 2004.
Mabgen is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
Mabgen was founded in 2004 in Houston, United States, and operates within the biotechnology sector focused on drug discovery tools. Cytotoxicity screening devices are developed to aid in identifying potential treatments. The Ab-Sniffer, a fiber optic fluorescence-based device, is provided for detecting functional drug candidates applicable to cancer and various other diseases. Operations emphasize precision in screening processes for pharmaceutical research.
Mabgen's top competitors include Altis Biosystems and Aurita Bioscience Corporation.